Takeda is buying Ariad Pharmaceuticals in a $5.2 billion Deal

The Japanese pharmaceutical company Takeda is buying Cambridge, Massachussets-based Ariad Pharmaceuticals for $24 a share. The deal is valued at about $5.2 billion and expected to close in February...
Login to comment.